insulin

all catalysts(2)

News(10)

• Novo takes first round of oral obesity duel. Can it stay ahead of Lilly?
  Despite coming away with an early victory over Eli Lilly in the oral obesity face-off, analysts don’t expect Novo Nordisk’s lead to last for very long.
  biospace · 6d ago
• STAT+: Pharmalittle: We’re reading about a setback for Eyepoint, a win for Amylyx, and more
  Eyepoint disclosed that a Phase 3 trial of its experimental treatment for a common cause of age-related blindness fell short of its primary goal
  stat · 7d ago
• Amylyx’s bet on a GLP-1 blocker pays off
  A late-stage trial found the drug, which Amylyx bought for cheap in a bankruptcy auction, was effective at regulating blood sugar in patients who’d just undergone bariatric surgery.
  biopharma_dive · 7d ago
• Amylyx eyes FDA filing for GLP-1 blocker after late-stage win in post-bariatric hypoglycemia
  With a Phase 3 trial showing a reduction of serious and severe hypoglycemic episodes in patients who have undergone weight loss surgery, Amylyx Pharmaceuticals plans to file for approval this year.…
  biospace · 7d ago
• STAT+: Pharmalittle: We’re reading about an AstraZeneca setback, falling U.S. drug prices, and more
  AstraZeneca is discontinuing a late-stage drug trial in patients with metastatic non-small cell lung cancer, extending a run of setbacks
  stat · 8d ago
• STAT+: Kennedy’s split-screen week: Talk of vaccines in D.C., fraud and addiction out West
  The California trip shows how Kennedy likes to focus on key MAHA themes, while avoiding some divisive topics.
  stat · 8d ago
• STAT+: Up and down the ladder: The latest comings and goings
  From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
  stat · 11d ago
• STAT+: Pharmalittle: We’re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more
  The FDA approved a Bristol oral treatment for advanced multiple myeloma, marking the debut of a new class of medicine for the blood cancer
  stat · 11d ago
• STAT+: Drug-testing lab that has sparked controversy sues group that develops drug standards over criticism
  A lab that tussled with regulators over impurities found in widely used medicines has accused U.S. Pharmacopeia of making false and misleading remarks about its methods.
  stat · 11d ago
• Two years after rules overhaul, have methadone clinics really changed?
  Methadone clinics don't have to be as rigid in how they dispense opioid addiction medicine. Some, though not all, are changing their ways.
  stat · 11d ago